EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Investing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-5.17 Cr | ₹-13 Cr | ₹-16 Cr | ₹-17 Cr | ₹-12 Cr |
What is the latest Cash Flow from Investing Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-5.17 Cr |
| Mar2024 | ₹-13 Cr |
| Mar2023 | ₹-16 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹-12 Cr |
How is Cash Flow from Investing Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-5.17 Cr | Negative | |
| Mar2024 | ₹-13 Cr | Negative | |
| Mar2023 | ₹-16 Cr | Negative | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹-12 Cr | - | |
Compare Cash Flow from Investing Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹255.3 Cr | -2% | 17% | -17.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,663.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -2% |
17% |
-17.2% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses